Loading organizations...
Cecelia Health is a New York City-based health technology company that provides virtual care and telehealth coaching for chronic disease management. The organization operates a virtual specialty clinic model that utilizes certified specialists and algorithms to deliver personalized treatment plans for patients with diabetes, cardiovascular issues, and pulmonary conditions. Generating revenue through partnerships with healthcare providers, pharmacy benefit managers, and durable medical equipment companies, the firm is currently led by Chief Executive Officer Mark Clermont. To support its multi-disciplinary care initiatives and mental health services, the venture-backed enterprise has secured $35.3 million in total funding across four investment rounds. Originally founded in 2009 by David Weingard, the company has gained industry recognition from organizations like StartUp Health while operating with a workforce of approximately 350 employees and generating an estimated $73.5 million in annual revenue.
Cecelia Health has raised $24.0M across 4 funding rounds.
Cecelia Health has raised $24.0M in total across 4 funding rounds.
Cecelia Health has raised $24.0M across 4 funding rounds. Most recently, it raised $13.0M Series B in August 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 14, 2020 | $13M Series B | Eric Edidin, Saul Richter | Dana Callow, David Niles, Sustainvc | Announced |
| Sep 4, 2018 | $4M Venture Round | SJF Ventures | Blue Cross And Blue Shield OF Nebraska, C&B Capital, North Haven Capital, StartUp Health | Announced |
| Sep 1, 2018 | $4M Series U | SJF Ventures | OurCrowd, Rose Tech Ventures, Chaim Meir Tessler, Blue Cross And Blue Shield OF Nebraska, C&B Capital, North Haven Capital, StartUp Health | Announced |
| Aug 1, 2015 | $3M Series A | — | SJF Ventures | Announced |
# Cecelia Health: High-Level Overview
Cecelia Health is a virtual specialty medical practice, not primarily a technology company, though it leverages technology as a core enabler of its care delivery model.[1][2] Founded in 2009, the company provides virtual chronic care management and patient support programs designed to improve medication adherence and health outcomes for individuals with chronic conditions, particularly cardiometabolic diseases.[1][3] The company serves health plans, employers, health systems, providers, pharmaceutical manufacturers, and medical device companies.[3]
Cecelia Health's core value proposition centers on coordinated, clinically accountable virtual care rather than standalone digital tools or coaching platforms.[4] The company operates a comprehensive care team—including physicians, nurses, registered dietitians, certified diabetes care and education specialists, respiratory therapists, and care coordinators—that delivers medication management, medical nutrition therapy, behavior change support, and real-time clinical interventions.[4] This human-led approach, powered by data analytics, distinguishes Cecelia from purely software-based health platforms.
Cecelia Health was founded in 2009 and is based in New York.[3] The company was formerly known as Fit4D before rebranding to reflect its broader mission in virtual specialty care.[3] Over more than a decade of operation, Cecelia has built relationships with major stakeholders across the healthcare ecosystem—health plans, pharmaceutical organizations, and medical device manufacturers—establishing itself as a trusted partner for managing chronic conditions at scale.[1]
Cecelia Health operates at the intersection of digital health transformation and chronic disease management—two of the most pressing challenges in modern healthcare.[3] The company addresses a critical gap: while digital health tools and wearables have proliferated, patients with chronic conditions remain burdened by fragmented care experiences across disparate apps, providers, and support systems.[1]
The timing is favorable for Cecelia's model. Healthcare systems and payers are increasingly focused on value-based care, medication adherence, and cost reduction, particularly for high-cost cardiometabolic conditions that drive chronic care spending.[6] Cecelia's ability to demonstrate measurable improvements in adherence and health outcomes—validated through clinical studies like the ECLIPSE trial examining digital therapeutics for type 2 diabetes—positions it as a credible partner in this shift.[3]
Rather than competing with technology platforms, Cecelia leverages technology as infrastructure to enable human-centered clinical care at scale. This positions the company within the broader trend of human-in-the-loop digital health, where technology augments rather than replaces clinical judgment and patient relationships.
Cecelia Health's evolution reflects a maturing digital health market that increasingly values clinical outcomes over engagement metrics alone. As healthcare organizations demand evidence-based solutions with measurable ROI, Cecelia's positioning as a virtual medical practice—accountable for clinical results—offers differentiation from consumer-facing wellness apps.
The company's future likely hinges on expanding its clinical footprint across additional chronic conditions, deepening partnerships with pharmaceutical and medical device manufacturers seeking real-world evidence, and continuing to refine its data analytics capabilities to demonstrate value at multiple levels: individual patient, population, customer, and disease state.[5] As healthcare consolidation accelerates and payers seek integrated solutions, Cecelia's ability to operate as a trusted clinical partner—rather than a point solution—may prove increasingly valuable in a fragmented market.
Cecelia Health has raised $24.0M in total across 4 funding rounds.
Cecelia Health's investors include Eric Edidin, Saul Richter, Dana Callow, David Niles, SustainVC, SJF Ventures, Blue Cross and Blue Shield of Nebraska, C&B Capital, North Haven Capital, StartUp Health, OurCrowd, Rose Tech Ventures.